Answers are grounded in this paper and cite their sources.
Shows once-weekly well-day ketone testing predicts near-term diabetic ketoacidosis in type 1 diabetes, highlighting reduced monitoring burden.
OBJECTIVE: Independent of clinical risk factors, performing well-day capillary ketone monitoring over a month predicts near-term diabetic ketoacidosis (DKA) risk. We aimed to determine the minimum frequency of tests needed to maintain similar accuracy. RESEARCH DESIGN AND METHODS: Using regression and machine-learning gradient-boosted tree (GBT) models on the Empagliflozin as Adjunctive to Insulin Therapy 2 (EASE 2) and EASE 3 trial repository (n = 1,410), we simulated the testing frequencies of capillary ketones over a 1-month interval for predicting DKA or severe ketosis in the next month. RESULTS: Compared with the baseline twice-weekly ketone testing frequency, once-weekly well-day ketone testing was the lowest frequency that maintained prediction accuracy in maximum ketone models (area under the receiver operating characteristic curve 0.692 vs. 0.678; P = 0.19) and GBT models (0.719 vs. 0.711; P = 0.38). CONCLUSIONS: Weekly well-day capillary ketone testing, using existing strips before they expire, may provide a practical approach to stratify baseline DKA risk while reducing testing burden.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: